Latest news Press centre

Terminal
News feeds
Terminalnew

Subscription

Українська
Русский
English

Home

Facts Economy Sport Investments Diplomacy Regions Press Conferences Press Announcement Projects

Stories

Red Cross Restoration of Ukraine War Energy

Sections

Home
Facts
Economy
Sport
Investments
Diplomacy
Regions
Press Conferences
Press Announcement
Projects

Stories

Red Cross
Restoration of Ukraine
War
Energy

For clients

Terminal
News feeds
Terminalnew
Trial Access

About agency Products & Services Press centre Careers Contacts

Add as source

Tag

#msd

All materials

20 February Monday

09:23 MSD pharma company to supply first immuno-oncological medicine to Ukraine by late April

← Older 1 / 1 Later →

ADVERTISEMENT

ADVERTISEMENT

About agency

About agency
Contacts
Careers
Press centre

Agency products

News feeds
Issues
Terminal
Announcements

DnB
Energy Reform
Green Deal
Press-centre events

Subscription

Subscribe
News feeds
Terminal
Announcements

Follow us

Add as source

© 1992-2026, Interfax-Ukraine. All rights reserved
Interfax-Ukraine. All rights reserved
All information placed on this Web site is designed for internal use only. Its reproduction or distribution in any form is prohibited without the written permission from Interfax-Ukraine.
Commercial materials appear in the "Press releases", "Promo" and "Special projects" sections *. Interfax-Ukraine agency is not responsible for their content.
This online media is intended for persons over 21 years of age.
*In cases of public importance, publication in these sections is permitted free of charge.

All materials on the open part of this information resource are published with a delay of at least 15 minutes.
The site contains no more than 20% of the daily volume of Interfax-Ukraine agency materials.
Full access to on-line and off-line information products is available via a trial or contract subscription.
Copyright applies to all Interfax-Ukraine materials.